Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Checking in on Gold & Silver Sentiment

The precious metals sector remains in a correction. The miners have shown some positive signs but are not ready to move yet because the metals likely have more correction ahead. Technical support levels can provide us with low risk buy opportunities but combine that with s...

This Canadian Biopharmaceutical Co. is a Pioneer of the Medical Cannabis Industry

An evidence-based, scientific approach is how Avicanna Inc. ( TSX.AVCN , OTC: AVCNF , Forum ) gains its competitive advantage in the medical cannabis sector. The Canadian biopharmaceutical company has spent over four years in research & development before creating its m...

BioNTech, CureVac, EXMceuticals - reaching their goal with government support

In the fight against the spread of the Corona Pandemic, a great deal of commitment is required from companies. This situation also offers the opportunity to rethink and change existing work processes and procedures. Product ranges are being expanded and new possibilities and a...

Tired of Big Box Cannabis? Investors Should Consider the Craft Sector

The craft cannabis industry evolved in 2021 to become a major disruptor to big-box cannabis. Yet, micro-cultivators still face hurdles to get their product to market as demand from younger consumers increases. Solutions are needed. One company at the forefront of this chang...

Target Price Increased on Oil & Gas Company 'Poised for Continued Growth'

A Raymond James report provided reasons for the upward revision and detailed areas of potential growth for this Texas-based entity. In a March 8 research note, analyst John Freeman reported that Raymond James increased its target price to $24 per share from $22 and reit...

'Investors Need to Own' This Provider of Well Completion, Production Services

This energy company's growth and other prospects are discussed in a Raymond James report. In an April 12 research note, Raymond James analyst J. Marshall Adkins purported that Nine Energy Service Inc. (NINE:NYSE) is a "misunderstood stock within the oilfield sect...

MLP to Divest U.S. Gas Storage Assets, Focus on Refinery Services

The benefits of the deal to the partnership are discussed in a Raymond James report. In a June 10 research note, Raymond James analyst Justin Jenkins reported that Martin Midstream Partners L.P. (MMLP:NASDAQ) agreed to sell Cardinal Gas Storage, its Ar...

MLP Achieves 'Another Beat and Raise' in Q2/19

Performance during the quarter and guidance for the rest of 2019 are reviewed in a Raymond James report. In an Aug. 1 research note, Raymond James analyst Justin Jenkins reported that Magellan Midstream Partners L.P.'s (MMP:NYSE) Q2/19 results are positive,...

Oil & Gas Royalty MLP Benefits from 'Record Production in Q3/19'

The quarterly highlights are provided in a Raymond James report. In a Nov. 7 research note, Raymond James analyst John Freeman wrote that Kimbell Royalty Partners, LP (KRP:NYSE) "reported record production in Q3/19, making way for about an 8% sequential distribution...

Mesoblast Shares Soar 120% After Reporting 83% Survival Rate in COVID-19 Patients with ARDS

Shares of Mesoblast more than doubled and set a new 52-week high price after the company reported that it achieved a 83% survival rate in New York ventilator-dependent COVID-19 patients with moderate to severe acute respiratory distress syndrome who were treated with its all...
1 2 3 4 5 6 7 8 9 10 ...